Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Tan

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Nature Communications|September 26, 2019
Descent trajectory reconstruction and landing site positioning of Chang'E-4 on the lunar farsideJianjun Liu, Xin Ren, Wei Yan, et al.
Nature|May 17, 2019
Chang'E-4 initial spectroscopic identification of lunar far-side mantle-derived materialsChunlai Li, Dawei Liu, Bin Liu, et al.
Ebiomedicine|March 2, 2023
A small-molecule inhibitor of Keap1-Nrf2 interaction attenuates sepsis by selectively augmenting the antibacterial defence of macrophages at infection sitesYawei Wang, Binlin Tang, Huijuan Li, et al.
The ISME Journal|January 23, 2023
Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammalsMeng Li, Juan Du, Weiqiang Liu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 19, 2025
Unveiling Aqueous Potassium-Ion Batteries with Prussian Blue Analogue CathodesXu Tan, Chenyang Gao, Zhifen Luo, et al.
G3 (Bethesda, Md.)|June 2, 2018
Genotyping by Sequencing of 393 <i>Sorghum bicolor</i> BTx623 × IS3620C Recombinant Inbred Lines Improves Sensitivity and Resolution of QTL DetectionWenQian Kong, Changsoo Kim, Dong Zhang, et al.
Chinese Medical Journal|July 21, 2025
Novel CD19 Fast-CAR-T cells vs. CD19 conventional CAR-T cells for the treatment of relapsed/refractory CD19-positive B-cell acute lymphoblastic leukemiaXu Tan, Jishi Wang, Shangjun Chen, et al.
Nature Communications|May 23, 2023
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variantsWanbo Tai, Shengyong Feng, Benjie Chai, et al.
BMC Medicine|December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinomaNing Li, Tao Wu, Yong-Gui Hong, et al.
Cancer|April 28, 2011
Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetesBen-Xu Tan, Wen-Xiu Yao, Jun Ge, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Nature Communications|September 26, 2019
Descent trajectory reconstruction and landing site positioning of Chang'E-4 on the lunar farsideJianjun Liu, Xin Ren, Wei Yan, et al.
Nature|May 17, 2019
Chang'E-4 initial spectroscopic identification of lunar far-side mantle-derived materialsChunlai Li, Dawei Liu, Bin Liu, et al.
Ebiomedicine|March 2, 2023
A small-molecule inhibitor of Keap1-Nrf2 interaction attenuates sepsis by selectively augmenting the antibacterial defence of macrophages at infection sitesYawei Wang, Binlin Tang, Huijuan Li, et al.
The ISME Journal|January 23, 2023
Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammalsMeng Li, Juan Du, Weiqiang Liu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 19, 2025
Unveiling Aqueous Potassium-Ion Batteries with Prussian Blue Analogue CathodesXu Tan, Chenyang Gao, Zhifen Luo, et al.
G3 (Bethesda, Md.)|June 2, 2018
Genotyping by Sequencing of 393 <i>Sorghum bicolor</i> BTx623 × IS3620C Recombinant Inbred Lines Improves Sensitivity and Resolution of QTL DetectionWenQian Kong, Changsoo Kim, Dong Zhang, et al.
Chinese Medical Journal|July 21, 2025
Novel CD19 Fast-CAR-T cells vs. CD19 conventional CAR-T cells for the treatment of relapsed/refractory CD19-positive B-cell acute lymphoblastic leukemiaXu Tan, Jishi Wang, Shangjun Chen, et al.
Nature Communications|May 23, 2023
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variantsWanbo Tai, Shengyong Feng, Benjie Chai, et al.
BMC Medicine|December 9, 2022
A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinomaNing Li, Tao Wu, Yong-Gui Hong, et al.
Cancer|April 28, 2011
Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetesBen-Xu Tan, Wen-Xiu Yao, Jun Ge, et al.
Pageof 22